DOCUMENT 01 · AUGUST 2026

Investor Pitch Deck

EF Resonator — a programmable whole-body electromagnetic wellness and research platform. The investment thesis, architecture, commercialization plan, development gates, and Series A request.

The Ask

$15M Series A

To reach prototype, validation, and pilot readiness. Milestone-based — capital released against verified technical gates. Strategic syndicate — medtech, strategic, and family-office capital. Board governance — disciplined oversight of claims, risk, and spending.

A fragmented category creates an opening for trust

Current Gap

Inconsistent hardware

Limited controls, unclear specifications, and difficult servicing undermine confidence.

Evidence Gap

Variable protocols

Published research uses different frequencies, intensities, and treatment schedules.

Market Gap

Claim risk

Marketing that outruns evidence creates regulatory and adoption risk.

The thesis: engineer trust into every session

Programmable

Frequency, intensity, and duration controlled through one interface.

Whole-Body

Premium bed format designed for clinics, research sites, and wellness operators.

Measurable

Documented output, session logs, and repeatable protocols support validation.

Upgradable

Modular hardware and software allow controlled expansion over time.

One configurable platform, three integrated layers

Whole-body bed

Coil architecture, thermal monitoring, emergency shutoff, serviceable modules.

Control system

Programmable frequency, intensity and duration, preset protocols, session logging.

Research layer

Controlled parameters, de-identified outcomes, remote updates, future sensor inputs.

Clinical claims require separate evidence and regulatory review. The engineering program converts the concept into a documented, testable, and manufacturable platform.

Launch conservatively; expand with evidence

Phase	Positioning
1 · Wellness	General wellbeing and relaxation positioning, subject to counsel and risk assessment.
2 · Research	Partner protocols, controlled data collection, and investigator-led studies.
3 · Medical	Specific indications pursued only with evidence and the appropriate FDA pathway.
Claims governance	Central review of labeling, training, software presets, and customer communications throughout.

Start where premium wellness is already purchased

Market 01

Clinics

Longevity, chiropractic, physical-therapy, and sports-recovery operators.

Market 02

Performance

Premium gyms, recovery centers, professional teams, physical occupations.

Market 03

Research

Universities, veterinary programs, and investigators needing configurable field delivery.

Three revenue streams support one platform

Hardware

$150K–$250K

Target purchase price range.

Leasing

$4K–$8K

Target monthly lease range.

Recurring

Service + software

Support, updates, and data tools.

Preliminary model — customer discovery will determine the best mix of ownership, leasing, and recurring revenue.

Prove the model before scaling distribution

Pilot — 5–10 sites. Validate workflow, reliability, utilization, and user experience.
Reference sites — 20–30. Build case studies, service playbooks, and repeatable sales materials.
Scale — channel growth. Expand through clinic groups, distributors, research partners, and alliances.

Differentiation compounds across layers

Output

Calibrated, documented, and repeatable field delivery.

Experience

Whole-body form factor, intuitive controls, and operator workflow.

Data foundation

Session records and study-ready protocol management.

IP + know-how

Architecture, controls, safety systems, presets, and accumulated operational learning.

Evidence development is part of the product

Bench — verify output. Field mapping, electrical safety, thermal behavior, repeatability, EMC.
Human factors — verify use. Training, contraindications, labeling, workflow, adverse-event capture.
Studies — verify claims. Prospective protocols designed with independent investigators and regulatory counsel.

Three gates lead to pilot readiness

Gate	Timing	Scope
Engineer	0–9 months	Requirements, simulation, risk analysis, alpha prototype, supplier plan.
Validate	9–18 months	Beta units, safety and usability testing, design iteration, regulatory decision.
Pilot	18–30 months	Limited production, reference sites, service model, commercial-readiness decision.

A disciplined planning case can reach commercial scale

Illustrative revenue ramp	Y1	Y2	Y3	Y4	Y5
Revenue	$0M	$2M	$8M	$20M	$42M

Assumption — not a forecast. Pricing, adoption, margins, and timing must be validated through prototype and customer discovery. Capital-efficient entry: engineering and validation first; commercial expansion follows measurable readiness gates.

Use $15M to remove the highest technical risks

Allocation	Share	Amount
Engineering + prototype	35%	$5.25M
Testing + regulatory	20%	$3.00M
Clinical + research evidence	15%	$2.25M
Software + data platform	12%	$1.80M
Team + operations	10%	$1.50M
Contingency + working capital	8%	$1.20M

Proposed allocation; final budget follows engineering quotations and regulatory counsel.

Build the leadership bench before scaling

Business lead

Capital formation, partnerships, governance, commercial accountability.

Engineering

Electromagnetics, power electronics, systems engineering, manufacturability.

Regulatory + quality

Classification, risk management, claims review, quality systems, testing.

Science

Independent expertise in biophysics, study design, clinical relevance, statistics.